Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Selective decrease of CD26 expression in T cells from HIV-1-infected individuals.

M V Blazquez1, J A Madueño, R Gonzalez

  • 1Departamento de Bioquímica, Biología Molecular y Fisiología, Hospital Reina Sofía, Universidad de Córdoba, Spain.

Journal of Immunology (Baltimore, Md. : 1950)
|November 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term response to aminopyridines in a cohort of patients with ataxia associated with downbeat nystagmus due to the FGF14 GAA expansion.

Neurologia·2026
Same author

The Morphological Dependence of PEDOT on the Supporting Electrolytes Used and the Acquisition of Gold Nanoparticles with a View to Their Use in the Covalent Modification of the Ki-67 Antibody.

Polymers·2025
Same author

Corrigendum to "Pilot therapeutic education program in multiple system atrophy: Safety, quality of life and satisfaction from a national registry based longitudinal study" [Park. Relat. Disord. (2024) 106993].

Parkinsonism & related disorders·2024
Same author

Is biochemical pregnancy loss associated with embryo or endometrium? A retrospective cohort study in frozen single embryo transfer of own and donated oocytes.

Human reproduction (Oxford, England)·2024
Same author

Pilot therapeutic education program in multiple system atrophy: Safety, quality of life and satisfaction from a national registry based longitudinal study.

Parkinsonism & related disorders·2024
Same author

Divergent Gut Microbiota: Archaeal and Bacterial Signatures Unveil Unique Patterns in Colombian Cyclists Compared to Weightlifters and Non-Athletes.

Advanced biology·2024

In individuals with AIDS, the CD26- subset of CD4+ T cells is a primary reservoir for HIV-1, contributing to immune system decline. This selective loss of CD26+ cells and preferential HIV-1 infection of CD26- cells illuminate AIDS pathophysiology.

Area of Science:

  • Immunology
  • Virology
  • Cell Biology

Background:

  • The decline of CD4+ T cells in AIDS patients is well-documented, but the mechanisms behind selective subset loss remain debated.
  • Understanding these mechanisms is crucial for comprehending HIV pathogenesis and immune deterioration.

Purpose of the Study:

  • To investigate the proliferative responses and phenotype profiles of CD4+ and CD8+ T cell subsets in HIV-infected individuals.
  • To determine the role of CD26 and CD29 expression in T cell function and HIV-1 infectivity.
  • To identify the primary reservoir of HIV-1 within CD4+ T cell subsets.

Main Methods:

  • Analysis of peripheral blood T lymphocyte proliferative response to antigens and mitogens.
  • Flow cytometry to assess CD26 and CD29 expression on CD4+ and CD8+ T cells.

Related Experiment Videos

  • Polymerase chain reaction (PCR) to detect HIV-1 DNA in CD26+ and CD26- T cell subsets.
  • In vitro infection assays to determine HIV-1 preferential infectivity.

    • Main Results:

    • CD26 antigen expression was significantly reduced on both CD4+ and CD8+ T cells in all tested HIV-infected patients.
    • T cells from these patients showed impaired proliferative responses to soluble antigens, despite unaffected CD29 expression.
    • PCR studies revealed the CD26- CD4+ T cell subset as the main HIV-1 reservoir in 11 out of 13 patients.
    • HIV-1 demonstrated preferential infectivity for the CD4+/CD26- T cell subpopulation in vitro.

    Conclusions:

    • The selective loss of CD26+ T cells and the preferential infection of CD26- T cells by HIV-1 contribute to the progressive immune impairment observed in AIDS.
    • These findings offer new insights into the pathophysiology of Acquired Immunodeficiency Syndrome (AIDS).
    • Targeting the CD26- T cell subset may be a potential therapeutic strategy in HIV/AIDS management.